Skip to content
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
featured-image

Press Release

RapidAI Highlights Research Depth and Industry Leadership at ISC 2026 With 28 Clinical Abstracts

SAN MATEO, CA (February 4, 2026) - RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced details of 28 scientific abstracts accepted at the International Stroke Conference (ISC) 2026, held February 4-6, at the Ernest N. Morial Convention Center in New Orleans. The abstracts span aneurysm monitoring, ischemic stroke detection, advanced imaging visualization, and radiology workflow optimization. Findings reflect the impact of deep clinical AI delivered through the Rapid Enterprise™ platform, designed to scale across radiology and acute workflows. The clinical data demonstrate how RapidAI’s clinically validated, FDA-cleared AI solutions can improve diagnostic performance, reduce interpretation time, and deliver measurable efficiency and economic gains for stroke teams and radiology departments. Rapid’s unique approach, called Deep Clinical AI, delivers real results by providing not just triage notifications but also visualization, localization, characterization, and tracking changes over time. The following abstracts highlight this approach and will be presented at the time below during ISC. Additional RapidAI abstract descriptions accepted by ISC can be found here.
featured-image

Press Release

RapidAI and AWS Strengthen Relationship: Accelerate Global Deployment of Deep Clinical AI

CHICAGO — December 1, 2025 — RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, and Amazon Web Services (AWS), today announced a strengthened working relationship to accelerate the global adoption and scalability of deep clinical AI in healthcare. The companies will focus on co-development and go-to-market alignment, bringing together AWS’s AI infrastructure and machine learning pipelines with RapidAI’s deep clinical expertise and multimodal healthcare data.
featured-image

Press Release

RapidAI Extends the Reach of Deep Clinical AI with Five New FDA Clearances

SAN MATEO, Calif. — November 25, 2025 — RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced the U.S. Food and Drug Administration (FDA) clearance of five new imaging modules: Rapid DeltaFuse™, Rapid LMVO, Rapid MLS, Rapid OH, and Rapid Aortic for measurement. Together, these clearances mark a significant expansion of the Rapid Enterprise™ Platform, reinforcing RapidAI’s identity as the only platform purpose-built to bring deep clinical intelligence, seamless workflow integration, and secure IT infrastructure to hospitals worldwide.
featured-image

Press Release

RapidAI Earns FDA Clearance for Rapid Aortic, Bringing AI-Driven Aortic Measurements and Surveillance to Care Teams

SAN MATEO, Calif. — November 18, 2025 — RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the Rapid Aortic product, a comprehensive deep clinical AI solution designed to transform the acute assessment and longitudinal management of aortic disease.
featured-image

Press Release

RapidAI and Health Holdings Company Partner to Bring Deep Clinical AI To Saudi Arabia

San Mateo, Calif. and Riyadh, Saudi Arabia — November 11, 2025 — RapidAI, the pioneer of Deep Clinical AI and global leader in intelligent imaging and workflow integration, today announced a strategic partnership and co-development with Saudi Health Holdings Company (HHC), the largest healthcare provider in the Middle East. Through this collaboration, RapidAI will serve as HHC’s enterprise provider of deep clinical AI across its 20 health clusters network of hospitals and clinics, supporting multiple disease states in neurology, cardiology, vascular, oncology, orthopedic and beyond.
featured-image

Press Release

Baptist Health Strengthens Statewide Stroke Care Network with RapidAI’s Deep Clinical AI

LITTLE ROCK, Ark. — October 29, 2025 — In recognition of World Stroke Day, Baptist Health, Arkansas’ most comprehensive health care organization, is highlighting how its partnership with RapidAI, the global leader in deep clinical AI and workflow integration, is helping clinicians across the state deliver faster, more connected care for stroke patients.
featured-image

Press Release

Lumina 3D by RapidAI Named to TIME’s List of the Best Inventions of 2025

San Mateo, Calif. — October 9, 2025 // RapidAI, the pioneer of deep clinical AI and the global leader in image-based decision support and workflow efficiencies, today announced that its Lumina 3D™ built on the Rapid Enterprise™ Platform has been named to TIME’s List of the Best Inventions of 2025, honoring 300 extraordinary innovations changing the way we live, work, and care for one another.
featured-image

Press Release

Tift Regional Medical Center Advances Stroke Care with RapidAI’s Deep Clinical AI

TIFTON, GA – August 18, 2025 – In a move to advance stroke care and accelerate critical decision-making, Tift Regional Medical Center (TRMC) has implemented RapidAI’s deep clinical AI platform, bringing faster insights and improved coordination to stroke response teams. The technology is now live across TRMC’s stroke program and is already helping clinicians deliver more timely and informed care. RapidAI, whose platform has helped shape the modern stroke treatment window, uses clinically validated AI to analyze brain images in real time. The solution helps physicians identify blood clots, brain bleeds, and changes in brain tissue to support urgent treatment decisions. “When it comes to stroke, every minute matters,” said Jeff Robbins, Director of Neurodiagnostics/Telehealth. “RapidAI gives our physicians fast, accurate data that helps clarify stroke severity and support collaborative decisions in the most critical moments. That level of insight can truly make a difference in patient outcomes.” The introduction of RapidAI is part of TRMC’s broader effort to integrate the most advanced technology into care pathways. The platform supports stroke care by:
featured-image

Press Release

New Study Finds RapidAI Significantly Outperforms Viz.ai in Detecting Medium Vessel Occlusions in Stroke Patients

RapidAI detects 33% more MeVOs than Viz.ai, with new real-world data presented at ESOC highlighting superior accuracy and deeper clinical insights
1 2 3